Synthetic Biology grants

Closed

Awards 15,000 Euro plus exhibition space and mentoring to the winning early-stage company at the ACHEMA Start-up Award 2027, for new ventures in chemistry, process engineering or biotechnology.

Closed

Funds UC Berkeley STEM faculty moving research discoveries toward commercially viable products and services.

Closed

Funds joint UC Berkeley and UCSF teams translating translational research into healthcare impact.

Closed

Supports early-career United Kingdom bioscientists with fellowships that build independent innovation leadership.

Closed

Supports United Kingdom teams through follow-on funding to move discovery innovation toward commercialization.

Closed

Funds biodiscovery projects that use AI and digital tools to find and sustainably produce new natural compounds from marine and freshwater organisms.

Closed

Supports biosecurity research, policy work, and prevention planning for pandemic preparedness.

Closed

Funds UK-based organisations developing biosecurity innovations across biodetection, AI diagnostics, and non-pharmaceutical protective systems for national security.

Closed

Supports United Kingdom innovators building systems to detect and respond to biological risk faster.

Closed

Supports United Kingdom biosecurity teams with innovation in sensing, diagnostics, and preventive systems.

Closed

Funds Indian deep-tech biotech startups, SMEs and large industries scaling indigenous manufacturing.

Closed

Funds Austrian science-industry consortia transferring basic research toward industrial applications.

Closed

Funds preclinical translational research advancing therapies for inherited retinal degeneration and dry AMD.

Closed

Funds one €20M innovation project that scales alternative proteins, oils, fibres or specialty carbohydrates into safe, accepted food ingredients.

Closed

Funds one €20M project that turns bio-based chemicals and ingredients into safer, sustainable home and personal care products at industrial scale.

Closed

Funds organizations designing and early-stage testing of new vaccine candidates against CEPI priority pathogens and Disease X viral families, with awards up to $1M over 18 months.

Closed

Funds organizations conducting preclinical vaccine development for CEPI priority pathogens and Disease X exemplars through CEPI's Innovations call.

Closed

Provides research teams and institutions for CFF PTAC Collaborative Research Grant in biotechnology, synthetic biology, and medical technology.

Closed

Backs research teams and institutions for CFF PTAC Research Grant in biotechnology, synthetic biology, and medical technology.

Closed

Funds accredited research institutions developing treatments for congenital dystroglycanopathies with grants up to $50,000.

Closed

Funds accredited research institutions developing treatments and care improvements for congenital-onset laminopathies with grants up to $100,000.

Closed

Funds teams delivering high impact prototypes with milestone support for DASA Themed Competition Biosecurity Frontiers in defense innovation, biotechnology, and synthetic biology.

Closed

Supports DASA Themed Competition Future proofing Biosecurity Microbial Forensic Capability for practical innovation and measurable results.

Closed

Funds Indian companies and startups developing Bio-AI platforms for high-performance biomanufacturing.